Gregory Montalbano speaks with Paul Grand who is the Founder and CEO of MedTech Innovator. Paul runs MedTech Innovator as a stand-alone non-profit which is also the largest accelerator of medical technology in the world.

Together, Greg and Paul discuss the methods of mentoring and support offered to the entrepreneurial groups spanning medical device, digital health, and diagnostic applications. Paul will also outline the various MedTech Innovator industry as well as venture partner networks that support their members. Greg and Paul’s discussions will also include what MedTech Innovator looks for in a startup and how they can apply to the MedTech Innovator programs. Lastly, this podcast will also cover new MedTech innovative initiatives and exciting breakthroughs that are expected on the horizon from the MedTech Innovator member network.

MIDI Medical Product Development’s CEO, Gregory Montalbano speaks with Stephen Chambers, Managing Director, and Julie Wolf, Chief Science Officer of the Development Community IndieBio located in heart of New York City.

In this podcast, Stephen and Julie will be discussing in detail what IndieBio NY is all about. Listen for a deep dive into the inner workings of the IndieBio ecosystem. Together, with Greg, they will discuss the methods of mentoring and support offered to the IndieBio entrepreneurial groups spanning medical, scientific, and biotechnology applications. Stephen and Julie will also discuss the various IndieBio partner networks that support their entrepreneurs and what IndieBio looks for in a startup as well as how they can apply. This discussion also covers new innovative biotech and medtech initiatives and exciting breakthroughs that are expected on the horizon from the IndieBio entrepreneurial companies.

On Episode #2 of MIDI Innovation Vault™ Series; The Deep Dive into Medical & Scientific Accelerators, Incubator Labs and Development Communities, MIDI Medical Product Developments CEO, Gregory Montalbano speaks with Meghan Pinezich who is an Executive Team member of Columbia BioMedX, a biomedical engineering technology accelerator at Columbia University, formerly called the Columbia-Coulter Research Partnership.

Meghan completed her Bachelors in Chemical Engineering at the University of Virginia and Masters in Biomedical Engineering at Columbia University. Currently, Meghan is also a PhD candidate in the laboratory disciplines of Stem Cell and Tissue Engineering.

On today’s podcast, Greg and Meghan will be discussing in detail what Columbia BioMedX’s Accelerator program is all about. They will discuss the inner workings of the BioMedX as well as touch on Columbia’s larger Lab-to-Market Accelerator network.

Discussions will cover the BioMedX methods of mentoring and support for their entrepreneurial groups which include medical, scientific, and biotechnology applications. Mehgan will also review the various BioMedX corporate, university, industry as well as venture partner networks that support their members.

Meghan will also reveal what BioMedX looks for in a startup member and how they can apply to their programs.

Lastly, in today’s podcast discussion, Meghan will talk about new initiatives and breakthroughs that are expected on the horizon from the BioMedX member network. Real-world examples will be discussed on what she has personally experienced and saw as a BioMedX Participant and now as an Executive Program Manager.

In this release of MIDI’s Innovation Vault™ Podcast series principal, Gregory Montalbano hosts deep-dive one-on-one interviews with the Directors of seven top global MedTech and Biotech Accelerators, Incubator Labs, and Development Communities.

Episode 1, introduces and outlines the upcoming series including introductions to each organization's Directors. Greg will then discuss with each organization's Director, various topics involving mentoring and support methods offered to their members, whose technology applications span from medical devices, digital health, diagnostic applications, Biotech, and more.

Additionally, Greg will ask the Directors to share their industry knowledge, experience, insight, and best advice for MedTech start-ups covering topics such as:

- Their organizations' individual value proposition, methods, and approach when selecting, mentoring, and supporting an entrepreneurial group member.

In this episode, Greg gives his expert advice and golden nuggets of wisdom before diving in with each of the global Accelerator and Incubator lab's Directors in the coming episodes.

In the previous Podcast of this series, Chris Montalbano, CEO of MIDI, provided an overview of the INNOVATION ROADMAP™ as applied to Medical Device Development. He “opened up” the map with us and explained there are three key stops along this journey. We have already reviewed the first 2 stops which did not need to be deployed under the FDA-QSR and ISO-13485 Design Controls and Risk Management. These activities support a programmatic quality feedback loop as well as mitigate risk for Stop #3 of the Innovation Roadmap (Commercialization & Implementation) which does need to be deployed under FD-QSR & ISO 13485, and is greatly detailed in this episode.

In this methodical process, MIDI's DevelopmentDNA™, ISO-13485 compliant process details each step in Commercialization & Implementation (Stop 3)  under Design Controls and Risk Management.

The steps include instituting:

In this episode, Christopher Montalbano, CEO of MIDI steps us through the medical device development Innovation Roadmap. Listen in as Chris helps us pinch-in, or zoom-out on the map, or for those of us who remember using paper maps, we're going to "open up the map" to see the entire scope first and discuss the three key stops along this innovation journey.

Stop 1, Market Exploration, Discovering Opportunities.

Chris then takes us through a deep dive on Stop 1 and 2 with Stop 3 being discussed during the next podcast.

Additionally, during this podcast episode, Ryan Kraudel, VP of Valencell joins us as an expert in the area of biometric sensor technology. Valencell makes the biometric sensor technology and sensor systems that get integrated into consumer and medical wearable devices, and have a key focus on what are known as PPG sensors

In the previous episode, Chris Montalbano, CEO of MIDI, provided a detailed deep dive of Wearable IoMT Biosensory Devices. In this episode, Chris will elaborate on what Wearable IoMT Physiological Devices are all about by defining these devices, reviewing their application and then identifying challenges resulting in innovative design solutions.

In this episode, Chris Montalbano, CEO of MIDI, shares what biosensory devices are all about starting with defining these devices and then looking at the components which make up such devices. In a deeper dive, Chris also provides examples/ applications of these devices seen in everyday life and discusses the development and commercialization challenges tied to innovating solutions.

Chris Montalbano, CEO of MIDI, discusses what IoMT Wearables are, outlines some of the benefits they provide to the medical community, and then performs a deep dive on device sensor selection. Tune in to hear more about these devices embraced by users as lifestyle devices used in their daily environments. 

In Episode 4, titled Recommended Principals and Practices of Human Factors Engineering: The Deep Dive into AAMI HE75 and Methods for Human Factors Usability Research, we discuss and distill down this guidance documents usability research and development methods as related to what medical device developers need to know in order to generate well designed, safe and effective medical devices that will be recognized by the FDA